Published in PLoS Pathog on August 14, 2014
The Atomic Structure of the HIV-1 gp41 Transmembrane Domain and Its Connection to the Immunogenic Membrane-proximal External Region. J Biol Chem (2015) 0.94
Toll-Interacting Protein Suppresses HIV-1 Long-Terminal-Repeat-Driven Gene Expression and Silences the Post-Integrational Transcription of Viral Proviral DNA. PLoS One (2015) 0.75
TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes. Retrovirology (2016) 0.75
Toll-like receptor signalling. Nat Rev Immunol (2004) 34.74
Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell (2007) 6.55
Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. Proc Natl Acad Sci U S A (1988) 6.33
Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J Cell Sci (2002) 3.29
Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat Immunol (2009) 3.17
HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane. Immunity (2008) 3.01
Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe (2010) 2.81
Computational design of peptides that target transmembrane helices. Science (2007) 2.28
TOLL-like receptors linking innate and adaptive immune response. Vet Immunol Immunopathol (2003) 1.70
Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling. J Immunol (2011) 1.66
TLR2: cellular sensor for microbial and endogenous molecular patterns. Curr Top Microbiol Immunol (2002) 1.64
CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure. Immunol Rev (2013) 1.58
Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells. J Virol (2009) 1.53
Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence. J Leukoc Biol (2006) 1.42
Sensing of microbial molecular patterns by Toll-like receptors. Immunol Rev (2012) 1.39
Hiding in plain sight: how HIV evades innate immune responses. Cell (2011) 1.37
Motifs of two small residues can assist but are not sufficient to mediate transmembrane helix interactions. J Mol Biol (2004) 1.32
Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses. Cell Immunol (2007) 1.28
GALLEX, a measurement of heterologous association of transmembrane helices in a biological membrane. J Biol Chem (2002) 1.23
Lipid raft distribution of CD4 depends on its palmitoylation and association with Lck, and evidence for CD4-induced lipid raft aggregation as an additional mechanism to enhance CD3 signaling. J Immunol (2003) 1.23
Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligands. Cell Immunol (2008) 1.18
Transmembrane domains interactions within the membrane milieu: principles, advances and challenges. Biochim Biophys Acta (2011) 1.16
Pathogen recognition receptors: ligands and signaling pathways by Toll-like receptors. Int Rev Immunol (2013) 1.11
Signaling through Toll-like receptors triggers HIV-1 replication in latently infected mast cells. J Immunol (2004) 1.07
Activating immunity: lessons from the TLRs and NLRs. Trends Biochem Sci (2009) 1.03
Gram-positive bacteria enhance HIV-1 susceptibility in Langerhans cells, but not in dendritic cells, via Toll-like receptor activation. Blood (2009) 1.01
Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration. Hum Mol Genet (2013) 0.96
HIV-1 gp41 and TCRalpha trans-membrane domains share a motif exploited by the HIV virus to modulate T-cell proliferation. PLoS Pathog (2010) 0.92
Specific inhibition of a pathogenic receptor tyrosine kinase by its transmembrane domain. Biochim Biophys Acta (2010) 0.91
Location, location, location: is membrane partitioning everything when it comes to innate immune activation? Mediators Inflamm (2011) 0.86
Characterization of the interacting domain of the HIV-1 fusion peptide with the transmembrane domain of the T-cell receptor. Biochemistry (2008) 0.85
Assembly of the TLR2/6 transmembrane domains is essential for activation and is a target for prevention of sepsis. J Immunol (2013) 0.85
Activation of Toll-like receptor 2 increases macrophage resistance to HIV-1 infection. Immunobiology (2013) 0.83
HIV impairment of immune responses in dendritic cells. Adv Exp Med Biol (2013) 0.82
The cholesterol-binding motif of the HIV-1 glycoprotein gp41 regulates lateral sorting and oligomerization. Cell Microbiol (2014) 0.78
The spleen as a target in severe acute respiratory syndrome. FASEB J (2006) 0.78
Analyzing oligomerization of individual transmembrane helices and of entire membrane proteins in E. coli: A hitchhiker's guide to GALLEX. Methods Mol Biol (2013) 0.77
Organization of fluorescent cholesterol analogs in lipid bilayers - lessons from cyclodextrin extraction. Biochim Biophys Acta (2013) 0.84
Esculentin-1a-Derived Peptides Promote Clearance of Pseudomonas aeruginosa Internalized in Bronchial Cells of Cystic Fibrosis Patients and Lung Cell Migration: Biochemical Properties and a Plausible Mode of Action. Antimicrob Agents Chemother (2016) 0.80
DBD dyes as fluorescent probes for sensing lipophilic environments. Bioorg Med Chem Lett (2012) 0.79
An amphiphilic perylene imido diester for selective cellular imaging. Bioconjug Chem (2013) 0.75
Cell cycle dependent changes in the plasma membrane organization of mammalian cells. Biochim Biophys Acta (2016) 0.75
Recruitment of SH-containing peptides to lipid and biological membranes through the use of a palmitic acid functionalized with a maleimide group. Angew Chem Int Ed Engl (2014) 0.75